1989: PhD, Physical Anthropology, Pennsylvania State University
1980: MA, Anthropology, Pennsylvania State University
1977: BS, Biology/BS Anthropology, Florida State University

2020-: Professor and Leader, Modifiable Autism Risk Factors Research Program, AJ Drexel Autism Institute, Drexel University, Philadelphia, PA, USA.

2017-: Adjunct Professor, Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

2013-: Professor MSO, Aarhus University, dual position: Department of Public Health, Institute of Epidemiology and Social Medicine and Department of Economics and Business, National Centre for Register-based Research, Lundbeck Foundation Initiaitive for Integrative Psychiatric Research.

1993-2013: Centers for Disease Control and Prevention (CDC), Developmental Disabilities Branch, USA. Multiple positions; 2006-2013: Research Health Scientist, Team Lead (GS15);
2000-2006: Lead Health Scientist (GS14); 1997-2000: Acting Chief, Analytic Studies Section (GS14); 1993-1997: Epidemiologist (GS13).

1991-1992: Massachusetts Health Research Institute, Woburn Environment and Birth Study, Senior Epidemiologist.

1988-1990: Tufts University, Department of Sociology and Anthropology, Assistant Professor/Lecturer.

Awards
2012: CDC - Nominee - Charles C. Shepard Science Award.
2011: CDC - Nominee - Charles C. Shepard Science Award.
2011: Recognized by Autism Speaks for exceptional research achievements.
2010: CDC and ATSDR Honor Award 2009- Maternal Health Team–‘Excellence in Emergency Response’.
2009: Nominee, Outstanding Supervisor, Autism and Developmental Disabilities Monitoring Cerebral Palsy Network Team, 36th Annual Federal Employee of the Year Awards.
2005: Secretary of Health and Human Services’ Award for Distinguished Service–Autism Public Health Response Team.
2002: CDC and ATSDR Group Honor Award–Research Operational–Autism Public Health Response Team.
1997: Physicians Committee for Responsible Medicine - Research Innovation Award.
1997: CDC and ATSDR Honor Award - Research - Epidemiology and Laboratory.
1997: CDC - Charles C. Shepard Science Award. 
1996: CDC - NCEH Director's Award.


Committee/workgroup memberships
2019-2020: Member, Program Committee for the International Society for Autism Research (INSAR), Annual Meeting 2020 and 2021.
2019: Member, Expert Panel for the Qualitative Evaluation of completed ERC-funded projects, invitation from the European Research Council, Scientific Council.2015-2016: Topic Review Co-Chair, Epidemiology category, 2016 International Meeting for Autism Research.
2013-2016: Member, Mothers and Babies in Norway and Denmark (MOBAND).2011–: Member. Environmental Epidemiology in Autism Research Network organized by Autism Speaks and the National Institute of Environmental Health. Serve as external advisor on Network activities and initiatives.
2010-2014: Member, Task Force on Neonatal Encephalopathy and Cerebral Palsy formed by the American College of Obstetricians and Gynecologists charged with revision of the 2003 report entitled Neonatal Encephalopathy and Neurodevelopment.
2010-: Member, Scientific Advisory Committee for the initiative, Evaluation of the immune and physiologic response in children with autism following immune challenge, formed by a partnership between Autism Speaks and the MIND Institute.
2010-: International Society for Autism Research – International Meeting for Autism Research Diversity Committee member.
2009-2016: Scientific Advisory Board Member – Global Autism Public Health Ireland (GAPH-Ireland). GAPH-Ireland was formed by a partnership between Autism Speaks and Irish Autism Action. The GAPH-Ireland initiative is intended to assist IAA in their new focus on autism surveillance, research and training.
2009-2010: Member, Expert Advisory Panel for the Heinz Endowment in order to review and make recommendations regarding a study of the risk factors for childhood autism.
2008-2010: European Network for Surveillance of Risk Factors of Neurodevelopmental Disorders: Invited collaborator on multi-site EU effort to develop and improve mechanisms for compiling risk factor and biomarker data for multi-site analytic epidemiologic studies of neurodevelopmental disorders.
2007: Autism and Other Pervasive Developmental Disorders Conference Workgroup: invited participant and presenter to assess the status of the current research base and to identify short- and long-term research questions and opportunities that will enhance future revisions of the Diagnostic and Statistical Manual of Mental Disorders and the International Classifications of Diseases, Mental and Behavioral Disorders section. Convened under the auspices of the American Psychiatric Association (APA), the World Health Organization WHO, and the National Institutes of Health (NIH) with supplemental funding from the University of California Davis’ Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute.
2006-2009: European Autism Information System (EU-funded)
o September 2008: Invited consultant for planning of EAIS renewal, Cork, Ireland.
o October 2007: Invited speaker at Launch Event of the European Autism Alliance, Brussels.
2005-2009: Co-organizer for AS-CDC International Autism Epidemiology Network (IAEN), Chair - Registry workgroup;
2005-2007:NIMH Autism Phenome Workgroup; member of science advisory group for the Collaborative Autism Phenome Project.
2005-2008: Epidemiology Subcommittee member of Scientific Advisory Board - Autism Speaks.
2004: Core Member: Pregnancy and the Infant Working Group.

2018: PI, Sofiefonden, Services and support for autistic adults in Denmark. The study goal was to prepare a report of Denmark-specific results in the ASDEU on-line survey or autistic adult services in the EU.
2017-: Joint PI, NIH RO1 ES026993, Pollution and Neurodevelopment in Denmark (PANDa). Air pollution risk for Autism and ADHD - cross-disorder insights and genetic liability.
2015-2018: Lead, Adults Treatment and Care Work Package, Autism Spectrum Disorders in the European Union, European Union DG SANCO, begins Feb 2015, 20 partners at 14 EU study sites, 36 months' contract.
2015: PI, International Network Programme framework grant from Danish Agency for Science, technology and Innovation. For: Research Partnership in Mental Disorders between Aarhus University and Johns Hopkins University, USA: Psychiatric Epidemiology and Genetics Research Exchange (PEDIGREE).
2012-: Co-Director, Scientific and Analytic Oversight Committee, NIH Autism Center of Excellence. Multigenerational Familial and Environmental Risk for Autism (MINERvA) Network.
2003-2013: CDC, Principal Investigator (PI), Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE). Multi-site collaborative research network.
2003-2012_ CDC, PI, Study to Explore Early Development (SEED), CDC site. Multi-site case-control study of etiologic risk factors for autism.
2009-2013: PI, International Collaboration for Autism Registry Epidemiology (iCARE). Multinational, 8-site research consortium funded by Autism Speaks.
2002-2009: CDC, Science Lead: Collaborative Public Health Research Program in Denmark.
2000-2004: Project Officer, The Cost of Developmental Disabilities. Carried out under a contract with Research Triangle Institute.
1997-2000: Principal Investigator (PI), The Metropolitan Atlanta Developmental Disabilities Surveillance Program Early Identification of Children with Cerebral Palsy, CDC.
1996-2000: Co-Investigator, Infant Development Study. A CDC intramural case-control study of the protective effects of magnesium sulfate exposure in pregnancy on cerebral palsy in low birth weight children.
1993-1996: Project Officer, Surveillance of FAS in Pre-school Aged Children. Carried out under an ASPH-CDC cooperative Agreement with Emory University.

Professional journals: New England Journal of Medicine, JAMA, British Medical Journal, JAMA Psychiatry, JAMA Pediatrics, Lancet, Pediatrics, Biological Psychiatry, Molecular Psychiatry, American Journal of Epidemiology, American Journal of Public Health, Archives of General Psychiatry, British Journal of Psychiatry, International Journal of Epidemiology, Teratology, Journal for Autism and Developmental Disabilities, Reproductive Toxicology, Journal of Maternal-Fetal & Neonatal Medicine, Journal pf Pediatrics, American Journal of Obstetrics and Gynecology, American Journal of Perinatology, PlosOne, Obstetrics and Gynecology, Brain, Behavior and Immunity, Molecular Autism, Journal of Neuroinflammation, Society for Maternal Fetal Medicine, Wisconsin Medical Journal, Pediatric and Perinatal Epidemiology, Autism, Autism Research, Chronic Diseases in Canada, Early Human Development.

Grant applications: Autism Speaks/Environmental Epidemiology in Autism Research Network; Medical Research Council (UK), Neurosciences and Mental Health Board Applications; Faroese Islands Research Council; Autism Speaks-UK; Autism Science Foundation; National Institute of Mental Health (R01, R21 applications).

Reviewer for abstracts submitted for presentation at professional society meetings: International Meeting for Autism Research; Society for Pediatric Epidemiologic Research

2019: Benefits and challenges with ViPAR. At: Using Nordic register data to explore the co-evolution of health and social factors over the life course. Conference hosted by NordForsk of studies from the NordForsk call "Nordic Register Plots, combining social and health data in the Nordic countries. Panum Institute, University of Copenhagen, Copenhagen, 29 March 2019.
2018: What do we know of the transition from adolescent to adult services for persons with autism? Results from the literature and the multi-site ASDEU project. At: Aarhus Conference. Aarhus. October 6, 2018.
2018: Genetic and prenatal environmental factors in autism, ADHD and schizophrenia. At: Theme Day: Environment, Pregnancy and Child Development. Danish Board of Health Advisory Scientific Committee on Environment and Health. Copenhagen. 11 October 2018.
2018: What do we know of the transition from adolescent to adult services for persons with autism? At Viborg Kommune. Theme Day in Autism. Viborg, Denmark. 22 October 2018.
2018: Genetic and prenatal environmental factors in ASD, ADHD and schizophrenia: heterogeneity challenges biomarker discovery. At: Biomarkers in predictive toxicology and pharmacology: Risk assessment. Annual meeting of the Danish Society for Toxicology and Pharmacology. Sandbjerg Estate, Denmark. 8-9 November 2018.
2017: Comparative survey of services for adults with ASD in Europe: a multi-site assessment by the ASDEU consortium. At: Arapi 14th Autumn University. 2-6 October 2017, Le Croisic,France. 2017: Outcomes, services and care in adults with autism: an update from the Autism Spectrum Disorders in the European Union (ASDEU) project. Autism@Aarhus. 2017 Symposium: 6th Anniversary Meeting, 12 September 2017, Aarhus. 2016: Consequences of the marked increase in ASD prevalence. At: Challenges related to increased diagnosis ofchildren and adolescents with autism, autism spectrum disorders and ADHD: The Development Strategy 2016. Conference organized by Borgercentre Handicap, Copenhagen,18 November 2016. 
2016: Outcomes, services and care in adults with autism: an update from the Autism Spectrum Disorders in the European Union (ASDEU) project. Autism@Aarhus 2016 Symposium: 6th Anniversary Meeting, 27 September 2016, Aarhus. 
2016: Autism Spectrum Disorders in the European Union: what is being done for adult support and care? At the SIKON Conference, Landsforeningen Autisme, April 25-26, 2016, Odense, Denmark. 
2015: Transitions in a Danish Context. At the 8th Tryg Foundation Workshop on Applied Research for Mental Health in Children and Adolescents, Transition in Mental Health, Hindsgavl Slot, Denmark, December 1-2, 2015.
2015: Multidisciplinary Intervention for Youth in Transition. At the 8th Tryg Foundation Workshop on Applied Research for Mental Health in Children and Adolescents, Transition in Mental Health, Hindsgavl Slot, Denmark, December 1-2, 2015. 
2015: Population-based registries in autism research. At the ‘Wendy Klag Center for Autism and Developmental Disabilities. 2015 Fall Symposium’. Johns Hopkins School of Public Health. Baltimore, MD, USA, 13 October 2015.
2015: ASD in the EU: Overview of project and activities around adult support and care. Autism@Aarhus 2015 Symposium: 5th Anniversary Meeting, 10 September 2015, Aarhus.
2013: Can neonatal encephalopathy be prevented? Patient safety, clinical intervention, public health measures and surveillance. At ‘Neonatal Encephalopathy and Hypoxic Ischemic Encephalopathy: Advancing the Science and Improving Outcomes’, sponsored by Balnaves Foundation, NICHD, IMPACT for CP, Cerebral Palsy Alliance, Bethesday, MD, USA, May 2013.
2012: An overview of causes and risks for autism spectrum disorders. GSU Regents Center for Learning Disabilities, Disability Service Provider Meeting, June 28, 2012.
2010: Guest speaker, 9th Annual Pediatric Research Day jointly sponsored by the Department of Pediatrics and Human Development at Michigan State University and the Department of Pediatrics at Wayne State University, East Lansing, MI, Mar 12, 2010.
2009: Unraveling the causes of autism (and what is CDC doing about it)? Invited speaker and panelist for the symposium: Latest Moves in Unraveling Autismat the 2009 annual meeting of the Association of Healthcare Journalists, Seattle, WA, April 18, 2009
2008: What we know and what we need to know about the role of perinatal factors in autism. Invited Speaker for the Elizabeth Connelly Memorial Conference on Autism: Prenatal and Perinatal Issues, and Evidence-Based Assessment and Intervention, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY, April 17, 2008.
2007: Environmental Epidemiology: Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE). Autism and the Environment: Challenges and Opportunities for Research – A Workshop. Forum on Neuroscience and Nervous System Disorders, Institute of Medicine, Washington DC, April 18-19, 2007.
2006: Autism Surveillance and Epidemiologic Research at CDC. Michigan State University, Department of Epidemiology Seminar, January 12, 20062005: Autism Activities in the CDC – Denmark Collaboration. Interagency Autism Coordinating Committee Meeting, Bethesda, MD, November 18, 2005.
2004: The Epidemiology of Developmental Disabilities. Dansk Epidemiologisk Selskab, Hindsgavl Slot, Denmark, September 5, 2004.2004: Maternal immune system changes in term pregnancy. Measurement of Maternal and Fetal Infection and Inflammation in the National Children’s Study Workshop, Baltimore, MD. May 2004.
2004: CDC Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE). Interagency Autism Coordinating Committee Meeting, National Institutes of Health. Bethesda, MD, May 11, 2004.
2003: Developing a National Agenda Epidemiological and Environmental Research in Autism: Update on CDC Activities. Autism Summit Conference, Washington, DC. November 19-20, 2003.
1997: Magnesium sulfate exposure and the risk of cerebral palsy & mental retardation in very low birth weight survivors. Presented at the 1997 Frances Glenn Mayson Lecture, March 25, 1997, Crawford Long Hospital of Emory University, Atlanta, GA.
1996: Beyond Cerebral Palsy: Prenatal Magnesium Sulfate Exposure and the Risk for Mental Retardation. Presented at the Magnesium and Cerebral Palsy Hypothesis International Workshop, Oct 31- Nov 1, 1996. The University of Chicago, Chicago, Illinois.
1994:  The Woburn Environment and Birth Study: Reproductive Effects of Exposure to TCE-Contaminated Water. Seminar presented at the Emory University School of Public Health, Division of Environmental and Occupational Health.

Post-doctoral Fellow mentor
Three ongoing; 2 complete (Aarhus Unversity, Harvard Univesity, UCLA, USA)

PhD student thesis advisor
One ongoing (Aarhus University); eight complete (Aarhus University, Emory University, USA)

Active Support
NIH R01 A Reichenberg and D Schendel, joint PIs. 8/9/2019-5/31/2024. USD 3,499,418.
Autism Risk and Maternal Cardiometabolic Health (ARCH) study. The study goal is to determine the role of maternal CMCs and related familial and genetic factors in ASD etiology.

NIH R01 ES026993A Kalkbrenner and D Schendel, joint PIs. 4/1/17-2/28/22.USD 2,817,533.
Air-pollution risk for Autism and ADHD - cross-disorder insights and genetic liability. We will examine the risk for ASD and ADHD from prenatal air pollution exposure and risk-modifying effects of genetic liability.

Under review
NIH R01 A Kalkbrenner and D Schendel, joint PIs 3/2021-2/2026.USD 2,718,688.
The Influence of Air-pollution Exposure and Its Interplay with Genetics on Schizophrenia Risk. The project is designed to determine air pollutant effects on schizophrenia risk considering critical developmental periods, assess air pollutant exposure effects on schizophrenia risk while accommodating genetic variation, and examine air pollution risk effects among schizophrenia subgroups, while accommodating genetic variation.

Complete within last 3 years

Sofiefonden. Serviceydelser og behandling til voksne med autisme spektrum forstyrrelser i Danmark (Services and support for autistic adults in Denmark). April 2018-December 2018. 150,000 DKK. The study goal was to prepare a report of Denmark-specific results in the ASDEU on-line survey or autistic adult services in the EU.
Role: PI.

Service Contract NUMBER-Sanco/2014/C2/035European Commission DG SANCOPosada (PI) Feb 2015-Feb 2018. 
Autism Spectrum Disorders in the European Union (ASDEU Consortium)
The purpose of the project is to apply a public health model to ASD focused on prevalence estimation methods, early detection programs and the improvement of early diagnosis and intervention and the creation of a new European evidenced-based framework that will improve the care for both adults and elder people with ASDs.
Role: Denmark site PI and Lead, Adults Treatment and Care Work Package

U01 HD073978 Reichenberg (PI). 7/1/2012-6/30/2017
Multigenerational Familial and Environmental Risk for Autism (MINERvA) Network.USD 4,918,533 (total).
The goal of this study is to characterize multigenerational family characteristics and environmental exposures that can affect the risk for ASD building on an existing network leveraging established population-based epidemiologic resources from 7 countries.
Role: Co-investigator and co-Director, Scientific and Analytic Oversight Committee.

International Network Programme framework grant. Danish Agency for Science, Technology and Innovation. 1/17/2015-12/31/2015.DKK 200,614.
Research Partnership in Mental Disorders between Aarhus University and Johns Hopkins University, USA: Psychiatric Epidemiology and Genetics Research Exchange (PEDIGREE).
The purpose of the project was to boost capacity in psychiatric and genetic epidemiology in Denmark by initiating an international partnership between Aarhus University (AU; National Centre for Register-based Research) and Johns Hopkins University Bloomberg School of Public Health (JHSPH; Department of Mental Health and Department of Epidemiology, genetic epidemiology track), USA.
Role: PI (Awardee).

Autism Speaks. Schendel (PI). 2009-2013.
International Collaboration for Autism Registry Epidemiology (iCARE).Total funding (7 sites): USD 1,096,483.
The purpose of the project was to establish a multinational research consortium (Australia, Denmark, Finland, Israel, Norway, Sweden, USA) to promote register-based research in autism geographical and temporal heterogeneity, phenotype, family and life course patterns, and etiology.
Role: PI.

NOTE 1993-2013: Research Support Not Applicable (CDC/US Government Employee).

Department of Public Health, AU:

2018: Lecturer, AU International Summer School, Course title: Mother-Child Health. Course objective is to introduce how factors in the parent’s health and during pregnancy can influence the development and health of the fetus and the child up to the age of puberty.

Completed AU on-line training module entitled: Introduction to Teaching and Learning (InTel), March 2018.

2017: Chair, Assessment Committee for Professor at Aarhus University, Dept of Public Health.

2014-2017: Pre-assessor of PhD thesis proposals.

Section for Epidemiology, AU:

2018: Co-Lecturer, Epidemiology II. August 2018. Lecture: Information Problems.
2015: Autumn semester Supervisor, Bachelor Thesis Course for Medical Students, Reproductive Epidemiology.

Neonatal Encephalopathy and Neurodevelopment. Second Edition. 2014. Task Force on Neonatal Encephalopathy, American College of Obstetricians and Gynecologists. D Schendel: Chapter 1 lead with (in alphabetic order) N Badawi, E Blair, M Johnston, S McIntyre, K Nelson, L Papile, Y Wu.

Schendel D. Hypoxic-ischemic encephalopathy: epidemiology and long-term neurologic outcome. In: Neonatal Encephalopathy and Subsequent Cerebral Palsy: Defining the Pathogenesis and Pathophysiology. Report by the Task Force on Neonatal Encephalopathy, American College of Obstetricians and Gynecologists. 2003.

The Woburn Environment and Birth Study Research Team (DE Schendel, principal author). The Woburn Environment and Birth Study: Reports of the Retrospective Study Inter-Community Analysis, the Retrospective Study Wells G and H Analysis and the Prospective Surveillance Study. Vols I and II. 1994

Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment --- United States, 2003. Reported by: A Honeycutt, PhD, L Dunlap, MA, H Chen, MA, G al Homsi, MA, RTI International, Research Triangle Park, NC. S Grosse, PhD, D Schendel, PhD, National Center on Birth Defects and Developmental Disabilities, CDC. MMWR Morbidity and Mortality Weekly Report 2004; 53(3):57-59.

Vitamin A deficiency among children—Federated States of Micronesia, 2000. MMWR 2001; 50(24):509-12.

Mental retardation following diagnosis of a metabolic disorder in children aged 3-10 years - Metropolitan Atlanta Developmental Disabilities Surveillance Program. MMWR 1999; 48(17):353-56.

Boyle, CA, Yeargin-Allsopp M, Doernberg N, Holmgreen P, Murphy CC, Schendel DE. Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991. MMWR April 19, 1996; 45(SS-2): 1-14.

Link to My Bibliography: http://www.ncbi.nlm.nih.gov/sites/myncbi/1Nqwuu9CipnAi/bibliography/47414864/public/?sort=date&direction=ascending
Janecka M, Hansen SN, Modabbernia A, Browne HA, Buxbaum JD, Schendel DE, Reichenberg A, Parner ET, Grice DE. Parental age and differential risk for neuropsychiatric disorders: Data from a large national cohort. JAACAP (In press) 2018.
Sabourin KR, Reynolds A, Schendel D, RosenbergS, Croen L, Pinto-Martin JA, Schieve KL, Newschaffer C, Lee LC, DiGuiseppi C. Infections in children with autism spectrum disorder: Study to Explore Early Development. Autism Research (in press) 2018.
Schendel D, Thorsteinsson. Autism cumulative incidence into adulthood for birth cohorts in Denmark, 1980-2012. JAMA 2018 (in press). 
Croen LA, Qian Y, Ashwood P, Daniels J, FallinD, Schendel D, Schieve L, Singer A, Maffett M, Zerbo O. Family history of immune conditions and risk of autism spectrum disorders: findings from the Study to Explore Early Development. Autism Research 2018. First published online: 10 August 2018; https://doi.org/10.1002/aur.1979 
Andrews SV, Sheppard B, Windham GC, Schieve LA, Daniels J, Schendel DE, Croen LA, Chopra P, Alisch RS, Newschaffer CJ, Warren ST, Feinberg AP, Fallin MD, Ladd-Acosta C. Case-control meta-analysis of blood DNA methylation and autism spectrum disorder. Mol Autism 2018 Jun 28;9:40. doi: 10.1186/s13229-018-0224-6. eCollection 2018. 
Hannon E, Schendel D, Ladd Acosta C, Grove J, Hansen CS, Andrews S,Hougaard DM, Bresnehan M, Mors O, Hollegard MV, Bækvad-Hansen M, Hornig M, Mortensen PB, Buxbaum J, Fallin D, Bybjerg-Grauholm J, Reichenberg A, Mill J. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med. 2018 Mar 28;10(1):19. doi:10.1186/s13073-018-0527-4. 
Schendel, D. Prenatal antidepressant use and risk of autism: Should be viewed through the kaleidoscope of possible causes of autism. BMJ 201BMJ 2017;358:j3388 doi: 10.1136/bmj.j3388 (Published 2017 July19).
Denson LA, McDonald SA, Das A, Schendel DE, Skogstrand K, Hougaard DM, Shankaran S, Higgins RD, Carlo WA, Ehrenkranz RA; Cytokines Study Subcommittee of the NICHD Neonatal Research Network. Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol. 2017 Feb;34(3):240-247. doi:10.1055/s-0036-1585419. Epub 2016 Jul 25. 
Singer AB, Burstyn I,Thygesen M, Mortensen PB, Fallin MD, Schendel DE. Parental exposure to occupational asthmagens and risk of autism spectrum disorder in a Danish population-based case-control study. Environmental Health 2017;16: 31. 
Yipp B, Leonard H, Stock S, Stoltenberg C, Gissler M, Gross R, Schendel D, Sandin S. Autism risk in caesarean section. Int J Epidemiol. 2017 Apr1;46(2):429-439. doi: 10.1093/ije/dyw336 
Lyall K, Croen L, Daniels J, Fallin MD, Ladd-Acosta C, Lee BK, Park BY, Snyder NW, Schendel D, Volk H, Windham GC, Newschaffer C. The Changing Epidemiology of Autism Spectrum Disorders. Annu Rev Public Health. 2016 Dec 21. doi:10.1146/annurev-publhealth-031816-044318. [Epub ahead of print] 
Christensen J, Overgaard M, Parner ET, Vestergaard M, Schendel D. Risk of epilepsy and autism in full- and half-siblings – a population-based cohort study. Epilepsia 2016; 57: 2011-2018. 
Browne H, Modabbernia A, Buxbaum JD, Hansen SN,Schendel DE, Parner ET, Reichenberg A, Grice DE. Prenatal Maternal Smoking and Increased Risk for Tourette Syndrome and Chronic Tic Disorders. J Am Acad Child Adolesc Psychiatry. 2016 Sep;55(9):784-91. doi: 10.1016/j.jaac.2016.06.010. Epub 2016 Jul 21. 
Singer AB, Windham GC, Croen LA, Daniels JL, Lee BK, Schendel DE, Fallin D, Burstyn I. Maternal exposure to occupational asthmagens and autism spectrum disorder in the Study to Explore Early Development. J Autism Dev Disord. 2016 Aug 10. [Epub ahead of print]
DiGuiseppi C, Daniels J, Fallin D, Rosenberg S, Schieve L, Thomas K, Windham G, Bernal P, Currie D, Croen L, Goss C, Lee L-C, Miller L, Pinto-Martin J, Singer A, Soke G-N, Young L, Schendel D. Demographic profile of families and children in the Study to Explore Early Development (SEED): case-control study of autism spectrum disorder. Disabil Health J. 2016 Jan 29. pii: S1936-6574(16)00007-8. doi: 10.1016/j.dhjo.2016.01.005. [Epub ahead of print].
Meirer S, Mattheisen M, Mors O, Schendel DE, Mortensen PB, Plessen K. Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark. JAMA Psychiatry. 2016 Jan 27. doi:10.1001/jamapsychiatry.2015.3105. [Epub ahead of print] 
Schendel DE, Parner ET. Sibling comparisons and confounding in autism epidemiological studies. Letter. JAMA Psychiatry. 2016 Jan 13:1. doi:10.1001/jamapsychiatry.2015.2661. [Epub ahead of print] PMID:26764130 
Schendel DE, Overgaard M, Christensen J, Hjort L, Jørgensen M, Parner ET. Association of psychiatric and neurologic comorbidity with mortality among persons with autism spectrum disorder in a Danish population. JAMA Pediatr. 2016 Jan 11:1-8. doi: 10.1001/jamapediatrics.2015.3935. [Epub ahead ofprint] PMID:26752506 
Ladd-Acosta C, Shu C, Lee BK, Gidaya N, Singer A, Schieve LA, Schendel DE, Jones N, Daniels JL, Windham GC, Newschaffer CJ, Croen LA, Feinberg AP, M. Daniele Fallin. Presence of an Epigenetic Signature of Prenatal Tobacco Smoke Exposure in Childhood. Environmental Research 2016 Jan;144(Pt A):139-48. doi: 10.1016/j.envres.2015.11.014. Epub 2015 Nov 21. PMID:26610292 
Meier SM, Petersen L, Schendel DE, Mattheisen M, Mortensen PB, Mors O. Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk. PLoS One. 2015 Nov 11;10(11):e0141703. doi:10.1371/journal.pone.0141703. eCollection 2015. PMID:26558765 
Carter K, Francis R, Bresnahan M, Gissler M, Grønborg TK, Gross R, Gunnes N, Hammond G, Hornig M, Hultman CM, Huttunen J, Langridge A, Leonard H, Newman S, Parner ET, Petersson G, Reichenberg A, Sandin S, Schendel DE, Schalkwyk L, Sourander A, Steadman C, Stoltenberg C, Suominen A, Surén P, Susser E, Sylvester Vethanayagam A, Yusof Z; International Collaboration forAutism Registry Epidemiology. ViPAR: a software platform for the Virtual Pooling and Analysis of Research data. Intl J Epidemiol 2015. doi: 10.1093/ije/dyv193 
Atladottir HO, Schendel DE, Henriksen TB, Hjort L, Parner ET. Gestational age and autism spectrum disorder: trends in risk over time. Autism Research 2015. doi: 10.1002/aur.1525. [Epub ahead of print]. 
Wiggins LD, Levy SE, Daniels J, Schieve L, Croen L, DiGuiseppi C, Blaskey L, Giarelli E, Hepburn S, Lee L-C, Pinto-Martin J, Reynolds A, Rice C, Rosenberg CR, Thompson P, Yeargin-Allsopp M, Young L, Schendel D. Autism spectrum disorder symptoms among children enrolled in the Study to Explore Early Development (SEED). JADD 2015; DOI 10.1007/s10803-015-2476-8 
Sandin S, Schendel D, Magnusson P, Hultman C, Suren P, Susser E, Grønberg T, Gissler M, Gunnes N, Bresnahan M, Sourander A, Hornig M, Carter K, Francis R, Parner E, Leonard H, Rosanoff M, Stoltenberg C, Reichenberg A. Autism risk associated with parental age and with increasing difference inage between the parents. Molecular Psychiatry 2015; advance online publication, 9 June 2015; doi:10.1038/mp.2015.70. PMID:26055426 
Atladottir HO, Schendel DE, Parner ET, Henriksen TB. A descriptive study on the neonatal morbidity profile of autism spectrum disorders, including a comparison with other neurodevelopmental disorders. J Autism Dev Disord. 2015 Mar 11. [Epub ahead of print].
Streja E, Miller J, Wu C, Bech BH, Pedersen LH, Schendel DE, Uldall P, Olsen J. Disproportionate fetal growth and the risk for congenital cerebral palsy in singleton births. PLOS ONE 2015;10(5):e0126743. doi:10.1371/journal.pone.0126743. eCollection 2015.
Van Naarden Braun K, Christensen D, Doernberg N, Schieve LA, Rice C, Wiggins L, Schendel DS, Yeargin-Allsopp M. Trends in the Prevalence of Autism Spectrum Disorder, Cerebral Palsy, Hearing Loss, Intellectual Disability, and Vision Impairment, Metropolitan Atlanta, 1991-2010. PLOS ONE 2015;10(4): e0124120.doi:10.1371/journal.pone.0124120 
Browne HA, Hansen SN, Buxbaum JD, Gair SL, Nissen JB, Nikolajsen KH, Schendel DE, Reichenberg A, Parner ET, Grice DE, Familial clustering of tic disorders and obsessive compulsive disorder. JAMA Psychiatry 2015 Feb 18. doi:10.1001/jamapsychiatry.2014.2656. [Epub ahead of print] 
Hvidtjørn D, Wu C, Schendel D, Parner ET, Henriksen TB. Mortality in mothers after perinatal loss: a population based follow-up study. Brit J Obstet Gynecology 2015 Jan 6. doi: 10.1111/1471-0528.13268. [Epub ahead of print]
Hansen SN, Schendel DE, Parner ET. Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. JAMA Pediatr. doi:10.1001/jamapediatrics.2014.1893 Published online November 3, 2014.
Atladottir HO, Gyllenberg D, Langridge A, Sandin S, Hansen, SN, Leonard H, Gissler M, Reichenberg A, Schendel DE, Bourke J, Huiltman CM, Grice DE, Buxbaum JD, Parner ET. The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. Eur Child Adolesc Psychiatry. 2014 May 6. [Epub ahead of print]. 
Executive Summary: Neonatal Encephalopathy and Neurologic Outcome, Second Edition. Report of the American College of Obstetricians and Gynecologists’ Task Force on Neonatal Encephalopathy: Mary E. D’Alton, MD, Chair; Gary D.V. Hankins, MD, Vice Chair; Richard L. Berkowitz, MD; Jessica Bienstock, MD, MPH; Alessandro Ghidini, MD; Jay Goldsmith, MD; Rosemary Higgins, MD; Thomas R. Moore, MD; Renato Natale, MD; Karin B. Nelson, MD; Lu-Ann Papile, MD; Donald Peebles, MD; Roberto Jose Romero, MD; Diana Schendel, PhD; Catherine Yvonne Spong, MD; Richard N. Waldman, MD; Yvonne Wu, MD, MPH; and the American College of Obstetricians and Gynecologists’ staff: Gerald F. Joseph Jr, MD; Debra Hawks, MPH; Alyssa Politzer, MA; Chuck Emig, MA; and Kelly Thomas. Obstetrics & Gynecology 2014;123: 896–901. doi: 10.1097/01.AOG.0000445580.65983.d2
Schendel D, Grønborg T, Parner E. The genetic and environmental contributions to autism. Looking beyond twins. Invited editorial. JAMA. 2014;311(17):1738-1739. doi:10.1001/jama.2014.3554. 
Miller JE, Pedersen LH, Streja E, Bech BH, Yeargin-Allsopp M, Van Naarden Braun K, Schendel DE, Christensen D, Uldall P, Olsen J. Maternal bacterial infections during pregnancy and the risk of cerebral palsy in singleton births: a Danish population-based cohort study. Paediatr Perinat Epidmiol 2013; 27:542-552.
Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, Pedersen LH. Prenatal antidepressant exposure and risk of autism - a population-based study. Clinical Epidemiology 2013; 5 449–459.
Streja E, Miller JE, Bech BH, Greene N, Pedersen LH, Yeargin-Allsopp M, Van Naarden Braun K, Schendel DE, Christensen D, Uldall P, Olsen J. Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol 18 June 2013. pii: S0002-9378(13)00631-5. doi: 10.1016/j.ajog.2013.06.023. [Epub ahead of print]
Grønborg TK, Schendel DE, Parner E. The recurrence of autism spectrum disorders in Danish families: a population-based cohort study. JAMA Pediatrics 19 Aug 2013. DOI: 10.1001/jamapediatrics.2013.2259 [Epub ahead of print]
Lauritsen MB, Astrup A, Pedersen CB, Obel C, Schendel DE, Schieve L, Yeargin-Allsopp M, Parner ET. Urbanicity and Autism Spectrum Disorders. J Autism Devel Disord 27 Jun 2013 [Epub ahead of print] DOI 10.1007/s10803-013-1875-y 
Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner E, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism – a population-based study. JAMA 2013; 309(16):1696-703.
Schendel DE, Bresnahan M, Carter KW, Francis RW, Gissler M, Grønborg TK, Gross R, Gunnes N, Hornig M, Hultman CM, Langridge A, Lauritsen MB, Leonard H, Parner ET, Reichenberg A, Sandin S, Sourander A, Stoltenberg C, Suominen A, Surén P, Susser E. The International Collaboration for Autism Registry Epidemiology (iCARE): Multinational Registry-Based Investigations of Autism Risk Factors and Trends. J Autism Devel Disord 2013; 43(11):2650-63. 
Zhu JL, Hasle H, Correa A, Schendel D, Friedman JM, Olsen J, Rasmussen SA. Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark. Am J Med Genet A 2013;161(4):650-7.
Natarajan G, Shankaran S, McDonald S, Das A, Ehrenkranz RA, Goldberg RN, Stoll BJ, Tyson JE, Higgins RD, Schendel D, Hougaard D, Skogstrand K, Thorsen P and Carlo WA for the NICHD Neonatal Research Network Plasma Association between Blood spot Transforming Growth factor  (TGF ) and Patent Ductus Arteriosus in Extremely Low Birth Weight infants. Pediatr Cardiol 2013; 34(1):149-54.
Zhu JL, Hasle H, Correa A, Schendel D, Friedman JM, Olsen J, Rasmussen SA. Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med 2013;15(1):64-9. doi: 10.1038/gim.2012.93. Epub 2012 Aug 9.
Schendel D, Nelson K, Blair E. Neonatal encephalopathy or hypoxic-ischemic encephalopathy. Letter to the Editor. Annal Neurol 2012; 72(6): 984-5.
Atladóttir HÓ, Henriksen TB, Schendel DE, Parner ET. Autism after Infection, Febrile Episodes, and Use of Antibiotics during Pregnancy: an Exploratory Study. Pediatrics 2012; published online Nov 12, 2012 (DOI: 10.1542/peds.2012-1107).
Ambalavanan N, Carlo WA, McDonald SA, Das A, Schendel D, Thorsen P, Hougaard DM, Skogstrand K, Higgins RD for the Cytokine and GDB Subcommittees of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Cytokines Associated with Post-Hemorrhagic Ventricular Dilation in Premature Infants. Amer J Perinatology 2012; 29(9):731-740.
Atladóttir HÓ, Henriksen TB, Schendel DE, Parner ET. Using maternal reported data to investigate the association between childhood infection and autism spectrum disorder: the importance of data source. Paediatric Perinat Epidemiol 2012; 26:373-385.
Schendel DE, DiGuiseppi C, Croen LA, Fallin MD, Reed PL, Schieve LA, Wiggins LD, Daniels J, Grether J, Levy SE, Miller L, Newschaffer C, Pinto-Martin J, Robinson C, Windham GC, Alexander A, Aylsworth AS, Bernal P, Bonner JD, Blaskey L, Bradley C, Collins J, Ferretti CJ, Farzadegan H, Giarelli E, Harvey M, Hepburn S, Herr M, Kaparich K, Landa R, Lee L-C, Levenseller B, Meyerer S, Rahbar MH, Ratchford A, Reynolds A, Rosenberg S, Rusyniak J, Shapira SK, Smith K, Souders M, Thompson PA, Young L, Yeargin-Allsopp M. The Study to Explore Early Development (SEED): A Multisite Epidemiologic Study of Autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Network. JADD 2012; 42:2121–2140.
Atladóttir HÓ, Schendel DE, Lauritsen MB, Henriksen TB, Parner ET. Patterns of Contact to Hospital for Children with Autism Spectrum Disorders: a Danish Register Based Study. JADD 2012. Aug; 42(8):1717-28.
Schieve LA, Rice C, Devine O, Maenner MJ, Lee LC, Fitzgerald R, Wingate MS, Schendel D, Pettygrove S, Van Naarden Braun K, Durkin MS. Have secular changes in perinatal risk factors contributed to the recent autism prevalence increase? -- Development and application of a mathematical assessment model. Ann Epidemiol 2011; 21:930-945.
Carlo WA, McDonald SA, Tyson JE, Stoll BJ, Ehrenkranz RA, Shankaran S, Goldberg RN, Das A, Schendel D, Thorsen P, Skogstrand K, Hougaard DM, Oh W, Laptook AR, Duara S, Fanaroff AA, Donovan EF, Korones SB, Stevenson DK, Papile L, Finer NN, O’Shea TM; Poindexter BB, Wright LL, Ambalavanan N, Higgins RD, for the NICHD Neonatal Research Network. Cytokines and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. J Pediatrics 2011; 159(6):919-25.
Schelonka RL, Maheshwari A, Carlo WA, Taylor S, Hansen NI, Schendel DE, Thorsen P, Skogstrand K, Hougaard DM, Higgins RD for the Neonatal Research Network. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine 2011; 53(2):249-255.
Avchen RN, Wiggins LD, Devine O. Van Naarden-Braun K, Rice CE, Hobson N, Schendel D, Yeargin-Allsopp M. Evaluation of a record-review surveillance system used to determine the prevalence of autism spectrum disorders. J Autism Developmental Disorders 2011; 41: 227-236.
Hvidtjørn D, Grove J, Schendel D, Schieve L, Svaerke C, Ernst E, Thorsen P. Risk of Autism Spectrum Disorders in children born after assisted conception. A population-based follow-up study. J Epidemiol Community Health 2011; 65(6):497-502. 
Pearce B, Grove J, Bonney EA, Garvin S, Bliwise N, Dudley DJ, Schendel DE, Thorsen P. Interrelationship of MIF with other cytokines, HPA axis hormones, and psychosocial variables in the prediction of preterm birth. Gynecologic and Obstetric Investigation Gynecol Obstet Invest. 2010; 70(1):40-6. 
Atladóttir HÓ, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. Maternal Infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Developmental Disorders 2010; 40(12):1423-30.
Hvidtjorn D, Grove J, Schendel D, Svaerke C, Schieve LA, Uldall P, Ernst E, Jacobsson B, Thorsen P. Multiplicity and early gestational age contribute to an increased risk of cerebral palsy from assisted conception: a population-based cohort study. Human Reproduction 2010; 25(8): 2115-2123.
Schendel DE, Rice C, Cunniff C. The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities. Advances in Experimental Medicine and Biology 2010; 686:433-453.
Hamrick S, Strickland M, Shapira SK, Autry A, Schendel D. Use of special education services among children with and without congenital gastrointestinal anomalies. Am J on Intellectual and Developmental Disabilities 2010; 115: 421-432.
Atladóttir HÓ, Thorsen P, Schendel DE, Østergaard L, Lemcke S, Parner ET. The association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Archives of Pediatrics & Adolescent Medicine 2010; 164(5):470-7.
Kesmodel US, Underbjerg M, Kilburn T, Bakketeig L, Mortensen EL, Landrø NI, Schendel D, Bertrand J, Grove J, Ebrahim S, Thorsen P. Lifestyle during pregnancy: Neurodevelopmental effects at age 5 – the design and implementation of a prospective follow-up study. Scandinavian Journal Public Health 2010; 38: 208-219.
Sood BG, Madan A, Saha S, Shankaran S, Schendel DE, Thorsen P, Hougaard D, Skogstrand K, Carlo WA On behalf of the NICHD Neonatal Research Network. Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of Prematurity: Is there a Relationship? Pediatric Research 2010; 67: 394-400.
Lauritsen MB, Jørgensen M, Madsen KM, Lemcke S, Toft S, Grove J, Schendel DE, Thorsen P. Validity of Childhood Autism in the Danish Psychiatric Central Register - Findings From a Cohort Sample Born 1990-1999. Journal of Autism and Developmental Disorders 2010; 40:139-148.
Hvidtjorn D, Schieve LA, Schendel D, Grove J, Ernst E, Olsen J, Thorsen P. Validation of self reported data on assisted conception in the Danish National Birth Cohort. Human Reproduction 2009; 24: 2332-2340.
Schendel D, Autry A, Wines R, Moore C. The co-occurrence of autism and birth defects: prevalence and risk in a population-based cohort. Developmental Medicine & Child Neurology 2009; 51: 779-786. 
Curry AE, Vogel I, Drews C, Schendel DE, Skogstrand K, Flanders WD, Hougaard DM, Olsen J, Thorsen P. First-trimester maternal plasma cytokine levels, pre-pregnancy body mass index, and spontaneous preterm delivery. Acta Obstet Gynecol Scand 2009; 88:332-342.
Schendel D. Cerebral palsy and preterm birth: how far have we come? Pediatric Health 2009; 3: 111-113.
Namasivayam A, Carlo WA, D’Angio CT, McDonald SA, Schendel D, Thorsen P. Cytokines Association with Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants: A Role for T-lymphocytes? Pediatrics 2009; 123:1132-1141.
Schieve LA, Boulet SL, Boyle C, Rasmussen S, Schendel D. Health of children 3 to 17 years of age with Down syndrome in the 1997 – 2005 National Health Interview Survey. Pediatrics 2009; 123: e253-e260.
Hvidtjørn D, Schieve L, Schendel D, Jacobsson B, Svaerke C, Thorsen P. Cerebral palsy, autism spectrum disorders and developmental delay in children born after Artificial Reproductive Techniques: A systematic review and meta-analysis. Archives of Pediatrics & Adolescent Medicine 2009; 163:72-83.
Nielsen L, Schendel D, Grove J, Hvidtjørn D, Jacobsson B, Jossiassen T, Vestergaard M, Uldall P, Thorsen P. Asphyxia-related risk factors and their timing in cerebral palsy- a population based case-control study. Brit J Obstet Gynecol 2008; 115: 1518-1528.
Parner E, Schendel D, Thorsen P. Autism Prevalence Trends Over Time: The Confounding of Changes in Age at Diagnosis. Amer Academy Child Psychiatry 2008; 162 (12):1-8.
Maimburg RD, Væth M, Schendel DE, Hammer Bech B, Thorsen P. Neonatal Jaundice; a risk factor for Infantile Autism? Paediatric and Perinatal Epidemiology 2008; 22(6): 562-568.
Pearce BD, Garvin SE, Grove J, Bonney EA, Dudley DJ, Schendel DE, Thorsen P. Serum macrophage migration inhibitory factor in the prediction of preterm delivery. Am J Obstetrics and Gynecology 2008; 199: 46.e1-6.
Schendel D, Bhasin Karapurkar T. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics 2008; 121(6):1155-64.
Skogstrand K, Hougaard D, Schendel D, Nørgaard-Pedersen B, Thorsen P. Preterm birth may be associated with a sustained postnatal inflammatory response. Obstet Gynecol 2008; 111: 1118-1128.
Curry AE, Vogel I, Skogstrand K., Drews C, Schendel DE, Flanders WD, Hougaard DM, Thorsen P. Maternal plasma cytokines in early and mid-gestation of normal human pregnancy and their association with maternal factors. Journal of Reproductive Immunology 2008; 77(2):152-160.
Schendel D. Invited Commentary: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. Evidence Based Mental Health 2008; 11:32.
Curry AE, Vogel I, Drews C, Schendel DE, Skogstrand K, Flanders WD, Hougaard DM, Olsen J, Thorsen P. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery. Acta Obstetricia et Gynecologica Scandinavica 2007; 86(9):1103-1110.
Parner ET, Reefhuis J, Schendel D, Thomsen JL, Ovesen T, Thorsen P. Hearing loss diagnosis followed by meningitis in Danish children, 1995–2004. Otolaryngology-Head & Neck Surgery 2007; 136(3):428-33
Atladóttir HÓ, Parner ET, Dalsgaard S, Schendel D, Thomsen PH, Thorsen P. Variation in incidence of neurodevelopmental disorders with season of birth: an evaluation of four childhood-onset neuropsychiatric conditions. Epidemiology 2007; 18:240-245.
Newschaffer CJ, Croen LA, Daniels JL, Giarelli E, Grether JK, Kaparich KD, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Ratchford AM, Reaven J, Reynolds AM, Rice CE, Robinson C, Rosenburg SA, Schendel DE, Windham GC. The epidemiology of autism spectrum disorders. Annual Review of Public Health 2007; 28: 235-258.
Atladóttir HÓ, Parner ET, Schendel D, Dalsgaard S, Thomsen PH, Thorsen P. Time trends in reported diagnoses of childhood neuropsychiatric disorders: a Danish cohort study. Archives of Pediatrics & Adolescent Medicine 2007; 161:193-198.
Bhasin Karapurkar T, Schendel D. Sociodemographic risk factors for autism in a US metropolitan area. Journal of Autism and Developmental Disorders 2007; 37(4): 667-677.
Hvidtjørn D, Grove J, Schendel D, Væth M, Ernst E, Nielsen K, Thorsen P. Cerebral palsy in children born after in vitro fertilization: the role of preterm delivery – a population-based, cohort study. Pediatrics 2006; 118:475-482.
Rurangirwa JK, Van Naarden Braun K, Schendel DE, Yeargin-Allsopp M. Healthy behaviors and lifestyles in young adults with a history of developmental disabilities. Research in Developmental Disabilities 2006; 27:381-399.
Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Miranda M, Sørensen LC, Hougaard DM. Simultaneous determination of 25 inflammmatory markers and neurotrophins in neonatal dried blood spots by immunosassay xMAP technology. Clinical Chemistry 2005; 51:1854-1866.
Hvidtjørn D, Grove J, Schendel D, Væth M, Ernst E, Nielsen L, Thorsen P. “Vanishing embryo syndrome” in IVF/ICSI. Human Reproduction 2005; 20: 2550 - 2551. 
Larsson H, Eaton W, Madsen K, Vestergaard M, Olesen A, Agerbo E, Schendel D, Thorsen P, Mortensen PB. Risk factors for autism: Perinatal factors, parental psychiatric history and socioeconomic status. Am J Epidemiol 2005; 161:916-925.
Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, Schendel D, Melbye M, Olsen J. In reply. JAMA 2004; 292: 2083-2084.
Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, Schendel D, Melbye M, Olsen J. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004; 292: 351-357.
Schieve L, Rasmussen S, Buck G, Schendel D, Reynolds M, Wright V. Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstetrics & Gynecology 2004; 103(6):1154-1163.
Rice C, Schendel D, Cuniff C, Doernberg N. Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2004; 125C(1):22-27.
Van Naarden Braun K, Yeargin-Allsopp M, Schendel D, Fernhoff P. Long-term developmental outcomes of children identified through a newborn screening program with a metabolic or endocrine disorder: a population-based approach. J Pediatr 2003; 143:236-242.
Honeycutt A, Grosse S, Dunlap L, Schendel D, Chen H, Brann E, al Homsi G. Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment. In: Altman BM, Barnartt SN, Hendershot G, Larson S. ed. Using Survey Data to Study Disability. Results from the National Health Interview Survey on Disability. Research in Social Science and Disability, Volume 3: 207-228. London: Elsevier. 2003 
Cauci S, Thorsen P, Schendel DE, Bremmelgaard A, Viglino P, Quadrifoglio F, Guaschino S. Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes. J Clin Microbiol 2003; 41:435-438.
Madsen KM, Hviid A, Vestergaard M, Schendel DE, Wohlfart J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347:1477-1482.
Schendel DE, Schuchat A, Thorsen P. Public health issues related to infection in pregnancy and cerebral palsy. Mental Retardation and Developmental Disabilities Research Reviews 2002; 8:39-45.
Thorsen P, Schendel D, Deshpande AD, Vogel I, Dudley DJ, Olsen J. identification of biological/biochemical marker(s) for preterm delivery. Paediatric and Perinatal Epidemiology 2001; 15(suppl):90-103.
Schendel DE. Infection in pregnancy and cerebral palsy. J American Medical Women’s Association 2001; 56: 105-8. 
Boyle CA, Yeargin-Allsopp M, Schendel DE, Holmgreen P, Oakley GP. Tocolytic magnesium sulfate exposure and the risk for cerebral palsy among children with birth weights less than 1750 grams. Am J Epidemiol 2000; 152: 120-124. 
Murphy CC, Boyle C, Schendel D, Decoufle P, Yeargin-Allsopp M. Epidemiology of mental retardation. Mental Retardation and Developmental Disabilities Research Reviews 1998; 4:6-13.
Schendel DE, Stockbauer JW, Hoffman HJ, Herman AA, Berg CJ, Schramm WF. Relation between very low birthweight and developmental delay among preschool children without disabilities. Am J Epidemiol 1997; 740-749.
Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk of cerebral palsy. JAMA 1997; 277: 1033-1034 (reply).
Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation in very low birthweight children aged 3 to 5 years. JAMA 1996;276:1805-1810.